The Institutional Architecture
For investment committees, family offices, and counterparties underwriting a referral. Where the framework operates, what is disclosed, what is bounded, and what is not.
The disclosure below is the institutional spine of every engagement. It does not replace the engagement-specific agreements — it precedes them.
Two Operating Jurisdictions
One Defined Cross-border Protocol
Bangkok and Schwellbrunn operate under their own clinical authorities. Bilateral engagements are structured — never improvised.
J-01
Bangkok delivery
Clinical delivery operates from the AMSEL Bangkok center under Thai Ministry of Public Health licensure. Intake, intervention, and recalibration cycles are conducted on-site under the engaged control physician.
J-02
Sonnenberg authority
Methodology authority is held at BioMed Center Sonnenberg, Schwellbrunn, Switzerland. Sovereign and Continuum tier engagements include on-site cycles at Sonnenberg under direct methodology authority.
J-03
Cross-border posture
Bilateral cycles are operated under a defined cross-jurisdiction protocol. Travel, on-site logistics, and clinical handover are pre-structured — never improvised against a principal's calendar.
Confidentiality is the Operating Default — Not an Upgrade
Every engagement is bounded by a bilateral confidentiality agreement on intake. No public-facing artifact ever surfaces a principal.
D-01
Confidentiality on intake
Every engagement begins under a confidentiality agreement covering principal identity, biological data, indication, and the engagement structure itself. The agreement is bilateral.
D-03
Anonymisation in any reference use
Cohort statistics, indicative profiles, and any aggregate reporting are produced under irreversible anonymisation. No principal is referenceable from any public-facing AMSEL artifact.
D-02
Designated-office reporting
Briefings are issued only to the principal and to a named designated office. No third-party disclosure occurs without explicit written instruction from the principal.
D-04
Right to engagement closure
A principal may close the engagement at any cycle. On closure, biological data is either returned, retained under principal mandate, or destroyed — at the principal's instruction.
Capture · Residency · Access · Retention
Biological data is structured the same way an institutional asset is structured — under named control, defined access, and explicit retention discipline.
DP-01
Capture
Biological signal is captured under clinical control during defined cycles and continuously via approved wearable channels.
DP-02
Residency
Principal data resides on segregated infrastructure under the AMSEL Bangkok operating entity. Cross-border transfer to Sonnenberg occurs only for indicated cycles, under principal-authorised handover.
DP-03
Access
Access is limited to the engaged control physician, the methodology authority during indicated windows, and the designated office under principal mandate.
DP-04
Retention
Biological data is retained under cycle-aligned retention windows. Trajectory data is retained as long as the engagement remains open. On closure, retention defaults to the principal's instruction.
What the Framework is — And What it is Explicitly Not
The clearest signal of an institutional system is the discipline with which it bounds its own claims.
P-01
Not investment advice
AMSEL produces a measurement and a classification of biological risk. It does not produce investment advice, suitability assessment, or financial recommendations of any kind.
P-03
Operator network is downstream
AMSEL is the framework. The execution layer — clinical interventions activated against an ALRI band — operates under separate professional licensure. The framework measures; operators act on the measurement.
P-02
Not a diagnosis
The ALRI composite is a structured risk classification, not a clinical diagnosis. Where indicated, AMSEL refers principals into qualified clinical channels — never operating as the clinical channel itself.
P-04
Liability is structured
Engagement carries defined liability bounded by the clinical service contract. Methodology authority, control physician, and the AMSEL operating entity each carry their own framed responsibility within the engagement.